StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Current portion of loans & bonds by Quarter

Current portion of loans & bonds ($M) ($M)

QuarterlyAnnual

AstraZeneca Current portion of loans & bonds: -$2,859M in Q2 2026, down 35.9% from a year earlier.

Latest, Q2 2026
-2,859
Period ended Jun 30, 2026
Change on a year earlier
-35.9%
-4,461 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Where the Q2 2026 figure comes from

“|| Current instalments of loans | (2,859) | (2,460) | (4,461)”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Net Debt Table.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCurrent portion of loans & bonds ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026-2,859-35.9%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026-4,567+127.2%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025-2,460+22.6%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025-4,461+37,075.0%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025-4,461+121.1%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025-2,010-56.2%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024-2,007-56.5%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024-12-99.8%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024-2,018-51.2%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024-4,593+55.3%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023-4,614-7.1%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023-4,857+4.1%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023-4,135+192.2%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 2023-2,958+134.0%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022-4,964+289.9%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022-4,665+118.1%Form 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Current portion of loans & bonds ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/nd-current-loans

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.